Case Study: Fortune 1000 Pharmaceutical Products Company achieves enhanced IP protection and advanced threat detection with Fidelis Cybersecurity

Fortune 1000 Pharmaceutical Company Tightens Security with Fidelis Deception

Fortune 1000 Pharmaceutical Products Company, a global developer and manufacturer of therapies with more than 15,000 employees, needed to protect sensitive intellectual property and meet FDA/DEA compliance while securing communications with a broad supplier network. Facing sophisticated threats and the reality that prevention alone isn’t enough, the company selected Fidelis Cybersecurity’s deception solution, Fidelis Deception, to provide accurate alerts for malware infections and unauthorized access across endpoints, servers, and data repositories.

Fidelis Cybersecurity deployed Fidelis Deception decoys that mirror real assets and monitor egress traffic, managed from a centralized console that correlates multiple security engines. The solution detected advanced persistent and zero-day attacks (including malware missed by other tools), increased visibility into network assets and communication channels, and delivered more accurate, actionable alerts—helping the security team find intrusions that bypassed perimeter defenses and significantly improving threat detection and response.